Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Pharmasol Corporation
483
•Pharmasol Corporation•August 20, 2018

Pharmasol Corporation – FDA 483, Aug 20, 2018

Record Details

The U.S. Food and Drug Administration (FDA) conducted an inspection of Pharmasol Corporation, a human drug manufacturer located in South Easton, MA. The inspection spanned from July 23, 2018, to August 20, 2018. Following this assessment, an FDA Form 483 was issued to President Marc L. Badia on September 4, 2018. This document detailed nine distinct inspectional observations concerning conditions and practices found at the facility. While the specific nature of these observations is redacted within the provided text, a Form 483 generally indicates potential deviations from current manufacturing practices or other regulatory requirements. These findings are reported under the authority of Section 704(b) of the Federal Food, Drug and Cosmetic Act, which is designed to identify circumstances where a drug product might be considered adulterated, such as being prepared or held under insanitary conditions, or consisting of filthy or decomposed substances. The issuance of an FDA Form 483 requires Pharmasol Corporation to promptly investigate and formally respond to each observation, outlining corrective actions taken or planned to bring their operations into full compliance with federal health and safety standards for human drug manufacturing.

Company
Pharmasol Corporation
Inspection date
August 20, 2018
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Kellia N. Hicks (Investigator)
  • Sena G. Dissmeyer
  • Sean D. Duke (Vascular Neurologist Investigator)
View Company Profile

ID · 75e0111a-28f1-4400-82b4-86234cea0565

Other documents for Pharmasol Corporation
  • 483 - 2022-02-10February 10, 2022
  • 483 - 2021-06-14June 14, 2021
  • 483 - 2018-08-20August 20, 2018
  • 483 - 2015-07-16July 16, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmasol Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.